[go: up one dir, main page]

CA2568607A1 - Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la migration de cellules cancereuses - Google Patents

Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la migration de cellules cancereuses Download PDF

Info

Publication number
CA2568607A1
CA2568607A1 CA002568607A CA2568607A CA2568607A1 CA 2568607 A1 CA2568607 A1 CA 2568607A1 CA 002568607 A CA002568607 A CA 002568607A CA 2568607 A CA2568607 A CA 2568607A CA 2568607 A1 CA2568607 A1 CA 2568607A1
Authority
CA
Canada
Prior art keywords
carcinoma
substituted
aryl
alkyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002568607A
Other languages
English (en)
Inventor
Rene C. Gaudreault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marusyk Miller & Swain / Mbm & Co LLP
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2568607A1 publication Critical patent/CA2568607A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002568607A 2003-05-28 2004-05-28 Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la migration de cellules cancereuses Abandoned CA2568607A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47407403P 2003-05-28 2003-05-28
US60/474,074 2003-05-28
PCT/CA2004/000771 WO2004106291A1 (fr) 2003-05-28 2004-05-28 Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la migration de cellules cancereuses

Publications (1)

Publication Number Publication Date
CA2568607A1 true CA2568607A1 (fr) 2004-12-09

Family

ID=33490691

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002568607A Abandoned CA2568607A1 (fr) 2003-05-28 2004-05-28 Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la migration de cellules cancereuses

Country Status (2)

Country Link
CA (1) CA2568607A1 (fr)
WO (1) WO2004106291A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT311956B (de) * 1971-06-07 1973-12-10 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer Phenylimidazolidinonderivate und ihrer Salze
DE2806213A1 (de) * 1978-02-14 1979-08-16 Bayer Ag N-(omega-chloralkanoyl)-n'-trifluormethylphenyl-harnstoffe, verfahren zu ihrer herstellung und ihre verwendung als pflanzenschutzmittel
JPS61191667A (ja) * 1985-02-21 1986-08-26 Tokuyama Soda Co Ltd 尿素化合物
CA2116621C (fr) * 1993-03-03 2001-07-24 Rene C. Gaudreault Agents anticancereux
US5750547A (en) * 1995-01-06 1998-05-12 Universite Laval Certain carbanate anti-cancer agents

Also Published As

Publication number Publication date
WO2004106291A1 (fr) 2004-12-09

Similar Documents

Publication Publication Date Title
KR100453078B1 (ko) 신규 티오우레아 화합물 및 이를 함유하는 약제학적 조성물
US9062072B2 (en) Inhibitors of HIF and angiogenesis
DE69724811T2 (de) Pentafluorobenzensulfonamide und analoge
JP5832447B2 (ja) ビスアシル化ヒドロキシルアミン誘導体
RU2247109C9 (ru) Симметричные и несимметричные производные дифенилмочевины (варианты), фармацевтическая композиция, способ подавления роста опухолевых клеток, опосредованного киназой raf
CN114206832B (zh) 拮抗lpa1受体的脲化合物
WO2019018119A1 (fr) Méthodes de traitement de l'épilepsie et d'affections associées à kcnti
US7173060B2 (en) Oxime derivatives and their use as pharmaceutically active agents
CN101778563B (zh) 调节细胞凋亡的组合物和方法
EA020374B1 (ru) Производные бензолсульфонамида, фармацевтические композиции на их основе и применение
KR20110050745A (ko) 혈관항상성 유지제 및 그의 사용 방법
JP2006515003A (ja) 新規なＮ−モノアシル化ｏ−フェニレンジアミン、それらの縮合複素環式誘導体および製剤としてのそれらの使用
JP4171656B2 (ja) Ｎ−（アリール）−２−アリールエテンスルホンアミド及びその製薬用途
JP6987125B2 (ja) 新規２，４，６−三置換ｓ−トリアジン化合物並びにその製造方法および使用
KR100556158B1 (ko) 신규 엔-하이드록시 티오우레아, 우레아 및 아미드계화합물 및 이를 함유하는 약제학적 조성물
EA029058B1 (ru) Фторфенилпиразольные соединения
CA2568607A1 (fr) Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la migration de cellules cancereuses
WO2019089940A1 (fr) Méthodes de traitement de l'épilepsie et d'états neurologiques associés
US20190321345A1 (en) GLUT4 Selective Inhibitors for Cancer Therapy
KR102487130B1 (ko) 신규 메틸설폰아미드 유도체 화합물의 암전이 억제용 조성물
KR102121680B1 (ko) 설파메이트 유도체 화합물, 이의 제조 방법 및 용도
WO2004106292A1 (fr) Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la proliferation cellulaire pathogene non cancereuse et les maladies y etant associees
AU2014286221B2 (en) N-(1-cyano-2-hydroxy-1-methyl-ethyl)-4-(trifluoromethylsulfanyl)benzamide derivatives for use as nematocidal drugs
CN115073442B (zh) 含双硫键化合物、及其制法和药物组合物与用途

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead